B
CBST

Baird’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

Baird’s Portfolio CBST Stock Details CBST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-3,556
Closed -$260K – 1219
2014
Q1 		$260K Sell
3,556
-234
-6% -$17.4K ﹤0.01% 1017
2013
Q4 		$261K Buy
3,790
+155
+4% +$10K ﹤0.01% 1010
2013
Q3 		$231K Buy
+3,635
New +$220K ﹤0.01% 990

Other funds holding CBST

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Baird's CBST Position: Q2 2014 in Review

Baird sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q2 2014, closing a stake of 3,556 shares — an estimated $260K sold.

Baird first reported a position in CBST in Q3 2013 and held it in 3 quarters. The position peaked at $261K in Q4 2013. 270 funds tracked by Wall St. Rank hold CBST as of Q2 2014.

  • Baird reported no remaining CUBIST PHARMACEUTICALS INC position as of Q2 2014 after selling out during the quarter.
  • Baird sold 3,556 CUBIST PHARMACEUTICALS INC shares in Q2 2014, an estimated $260K.
  • Baird first reported a position in CUBIST PHARMACEUTICALS INC in Q3 2013 and held it in 3 quarters.
  • Baird's CUBIST PHARMACEUTICALS INC position peaked at $261K in Q4 2013.
  • 270 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q2 2014.

Based on Baird's 13F filing for Q2 2014, filed 8 Aug 2014.